Folgen
Camilo Barbosa
Camilo Barbosa
Infectious diseases at University of Michigan
Bestätigte E-Mail-Adresse bei umich.edu
Titel
Zitiert von
Zitiert von
Jahr
Alternative evolutionary paths to bacterial antibiotic resistance cause distinct collateral effects
C Barbosa, V Trebosc, C Kemmer, P Rosenstiel, R Beardmore, ...
Molecular biology and evolution 34 (9), 2229-2244, 2017
1522017
Antibiotic combination efficacy (ACE) networks for a Pseudomonas aeruginosa model
C Barbosa, R Beardmore, H Schulenburg, G Jansen
PLoS biology 16 (4), e2004356, 2018
772018
Evolutionary stability of collateral sensitivity to antibiotics in the model pathogen Pseudomonas aeruginosa
C Barbosa, R Römhild, P Rosenstiel, H Schulenburg
eLife, 2019
692019
Temporal variation in antibiotic environments slows down resistance evolution in pathogenic Pseudomonas aeruginosa
R Roemhild, C Barbosa, RE Beardmore, G Jansen, H Schulenburg
Evolutionary applications 8 (10), 945-955, 2015
682015
Experimental evolution as an efficient tool to dissect adaptive paths to antibiotic resistance
G Jansen, C Barbosa, H Schulenburg
Drug Resistance Updates 16 (6), 96-107, 2013
652013
Travelling at a slug’s pace: possible invertebrate vectors of Caenorhabditis nematodes
C Petersen, RJ Hermann, MC Barg, R Schalkowski, P Dirksen, C Barbosa, ...
BMC ecology 15, 1-13, 2015
582015
Association between clinical antibiotic resistance and susceptibility of Pseudomonas in the cystic fibrosis lung
G Jansen, N Mahrt, L Tueffers, C Barbosa, M Harjes, G Adolph, ...
Evolution, medicine, and public health 2016 (1), 182-194, 2016
532016
Bottleneck size and selection level reproducibly impact evolution of antibiotic resistance
N Mahrt, A Tietze, S Künzel, S Franzenburg, C Barbosa, G Jansen, ...
Nature Ecology & Evolution 5 (9), 1233-1242, 2021
332021
Ten years of life in compost: temporal and spatial variation of North German Caenorhabditis elegans populations
C Petersen, M Saebelfeld, C Barbosa, B Pees, RJ Hermann, ...
Ecology and evolution 5 (16), 3250-3263, 2015
332015
Co-Evolutionary Dynamics of the Bacteria Vibrio sp. CV1 and Phages V1G, V1P1, and V1P2: Implications for Phage Therapy
C Barbosa, P Venail, AV Holguin, MJ Vives
Microbial ecology 66, 897-905, 2013
332013
Enhanced behavioral immune defenses in a C. elegans C-type lectin-like domain gene mutant
B Pees, A Kloock, R Nakad, C Barbosa, K Dierking
Developmental & Comparative Immunology 74, 237-242, 2017
262017
The Genomic Basis of Rapid Adaptation to Antibiotic Combination Therapy in Pseudomonas aeruginosa
C Barbosa, N Mahrt, J Bunk, M Graßer, P Rosenstiel, G Jansen, ...
Molecular biology and evolution 38 (2), 449-464, 2021
222021
Pseudomonas aeruginosa populations in the cystic fibrosis lung lose susceptibility to newly applied β-lactams within 3 days
L Tueffers, C Barbosa, I Bobis, S Schubert, M Höppner, M Rühlemann, ...
Journal of Antimicrobial Chemotherapy 74 (10), 2916-2925, 2019
212019
Variants in ampD and dacB lead to in vivo resistance evolution of Pseudomonas aeruginosa within the central nervous system
C Barbosa, KS Gregg, RJ Woods
Journal of Antimicrobial Chemotherapy 75 (11), 3405-3408, 2020
72020
Why is preventing antibiotic resistance so hard? Analysis of failed resistance management
S Zhou, C Barbosa, RJ Woods
Evolution, Medicine, and Public Health 2020 (1), 102-108, 2020
72020
The evolution of antibiotic resistance in an incurable and ultimately fatal infection: A retrospective case study
RJ Woods, C Barbosa, L Koepping, JA Raygoza, M Mwangi, AF Read
Evolution, Medicine, and Public Health 11 (1), 163-173, 2023
2023
Evolutionary Roads to Antibiotic Resistance in Pseudomonas Aeruginosa
C Barbosa
University of Kiel, 2017
2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–17